- Messages
- 861
- Type of diabetes
- Type 1
- Treatment type
- Insulin
Two sub headlines in the Diabetes Times coverage of EASD 2019
https://diabetestimes.co.uk/easd-highlights/
"Poor diabetes control cost NHS £3 billion in 2017/18"
"CGM shown to be beneficial in type 1 diabetes"
A total of 94 adults with type 1 diabetes were followed for three years. Those who used CGM saw significantly better HbA1c levels – 7% and 6.9% for the multiple daily injection and insulin pump groups, respectively – versus 7.7% and 8.0% for conventional self-monitors.
CGM users also saw significantly more time spent in range, as well as less time spent in hypoglycaemia.
The NHS can't afford to fund CGMs. Possibly because it's spending so much on the effects of poor control?
I'm sure I'm being very simplistic here but....
https://diabetestimes.co.uk/easd-highlights/
"Poor diabetes control cost NHS £3 billion in 2017/18"
"CGM shown to be beneficial in type 1 diabetes"
A total of 94 adults with type 1 diabetes were followed for three years. Those who used CGM saw significantly better HbA1c levels – 7% and 6.9% for the multiple daily injection and insulin pump groups, respectively – versus 7.7% and 8.0% for conventional self-monitors.
CGM users also saw significantly more time spent in range, as well as less time spent in hypoglycaemia.
The NHS can't afford to fund CGMs. Possibly because it's spending so much on the effects of poor control?
I'm sure I'm being very simplistic here but....